Status:
RECRUITING
The Feasibility of Cream for Treatment of Neonatal Hypoglycemia
Lead Sponsor:
Baylor Research Institute
Conditions:
Neonatal Hypoglycemia
Eligibility:
All Genders
Up to 24 years
Phase:
NA
Brief Summary
Prolact CR (cream) is a fat supplement that is derived from pasteurized human donor milk. It has been utilized in babies who are born premature in the neonatal intensive care unit (NICU) setting to im...
Eligibility Criteria
Inclusion
- Newborns at risk for hypoglycemia (born to mothers with diabetes, small for gestational age, large for gestational age, late preterm born 35 to 37 weeks gestational age)
Exclusion
- Newborns with major congenital anomalies
- Newborns directly admitted to the NICU form delivery room
Key Trial Info
Start Date :
October 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT07217483
Start Date
October 14 2024
End Date
December 31 2026
Last Update
October 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor Scott & White Medical Center - McKinney
McKinney, Texas, United States, 75071